Surgalign Holdings, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was USD 20.57 million compared to USD 21.83 million a year ago. Net loss was USD 39.11 million compared to USD 45.36 million a year ago.

Basic loss per share from continuing operations was USD 5.77. Diluted loss per share from continuing operations was USD 5.77. Basic loss per share was USD 5.77 compared to USD 9.82 a year ago.

Diluted loss per share was USD 5.77 compared to USD 9.82 a year ago.